Faulkingham Dell
SVP, CCO at AKBA
- Sold, on record
- $129k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 1, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AKBAAkebia Therapeutics, Inc.SVP, CCO
Sales by reason
0
Routine
4
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale AKBAPlan not statedJun 1, 2020 2020
Sold 6,426 shares at $11.58 ($74k)
Faulkingham Dell, CCO
Sold 8% of holdings ($926k position)73,574 shares leftFirst sale on recordFiling
- 2 Form 4 sale AKBAPlan not statedMar 1, 2021 +273 days
Sold 6,749 shares at $3.40 ($23k)
Faulkingham Dell, CCO
Sold 5% of holdings ($461k position)128,825 shares leftFiling
- 3 Form 4 sale AKBAPlan not statedApr 1, 2021 +31 days
Sold 952 shares at $3.40 ($3k)
Faulkingham Dell, SVP, CCO
Sold 0.7% of holdings ($469k position)137,025 shares leftFiling
- 4 Form 4 sale AKBAPlan not statedMar 1, 2022 +334 days
Sold 13,184 shares at $2.16 ($28k)
Faulkingham Dell, SVP, CCO
Sold 7% of holdings ($404k position)173,841 shares left2.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Mar 2, 2022 | AKBA | SVP, CCO | Form 4 sale | 13,184 | $28k | 7.0% | Plan not stated | SEC |
| Apr 1, 2021 | Apr 1, 2021 | AKBA | SVP, CCO | Form 4 sale | 952 | $3k | 0.7% | Plan not stated | SEC |
| Mar 1, 2021 | Mar 2, 2021 | AKBA | CCO | Form 4 sale | 6,749 | $23k | 5.0% | Plan not stated | SEC |
| Jun 1, 2020 | Jun 2, 2020 | AKBA | CCO | Form 4 sale | 6,426 | $74k | 8.0% | Plan not stated | SEC |